56 related articles for article (PubMed ID: 2234331)
1. Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee.
Lee WH
Neurosurgery; 1990 Sep; 27(3):389-95; discussion 396. PubMed ID: 2234331
[TBL] [Abstract][Full Text] [Related]
2. The FGF6 amplification mutation plays an important role in the progression and treatment of malignant meningioma.
Liang R; Tan B; Lei K; Xu K; Liang J; Huang J; Liang Y; Huang J; Zhang L; Shi X; Lv Z; Lin H; Wang M
Transl Oncol; 2024 Jul; 45():101974. PubMed ID: 38710133
[TBL] [Abstract][Full Text] [Related]
3. Emerging systemic treatment options in meningioma.
Mair MJ; Berghoff AS; Brastianos PK; Preusser M
J Neurooncol; 2023 Jan; 161(2):245-258. PubMed ID: 36181606
[TBL] [Abstract][Full Text] [Related]
4. Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution.
Lucas CG; Mirchia K; Seo K; Najem H; Chen WC; Zakimi N; Foster K; Eaton CD; Cady MA; Choudhury A; Liu SJ; Phillips JJ; Magill ST; Horbinski CM; Solomon DA; Perry A; Vasudevan HN; Heimberger AB; Raleigh DR
Nat Genet; 2024 May; ():. PubMed ID: 38760638
[TBL] [Abstract][Full Text] [Related]
5. Establishment of tumor microenvironment-preserving organoid model from patients with intracranial meningioma.
Kim D; Park J; Park HC; Zhang S; Park M; Park SA; Lee SH; Lee YS; Park JS; Jeun SS; Chung YJ; Ahn S
Cancer Cell Int; 2024 Jan; 24(1):36. PubMed ID: 38238738
[TBL] [Abstract][Full Text] [Related]
6. Meningioma animal models: a systematic review and meta-analysis.
Andersen MS; Kofoed MS; Paludan-Müller AS; Pedersen CB; Mathiesen T; Mawrin C; Wirenfeldt M; Kristensen BW; Olsen BB; Halle B; Poulsen FR
J Transl Med; 2023 Oct; 21(1):764. PubMed ID: 37898750
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs miR-16 and miR-519 control meningioma cell proliferation
Hergalant S; Casse JM; Oussalah A; Houlgatte R; Helle D; Rech F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF; Gauchotte G
Front Oncol; 2023; 13():1158773. PubMed ID: 37601663
[TBL] [Abstract][Full Text] [Related]
8. NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.
Choudhury A; Cady MA; Lucas CG; Najem H; Phillips JJ; Palikuqi B; Zakimi N; Joseph T; Birrueta JO; Chen WC; Bush NAO; Hervey-Jumper SL; Klein OD; Toedebusch CM; Horbinski CM; Magill ST; Bhaduri A; Perry A; Dickinson PJ; Heimberger AB; Ashworth A; Crouch EE; Raleigh DR
bioRxiv; 2023 Jul; ():. PubMed ID: 37503127
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Models of Meningioma.
Jungwirth G; Hanemann CO; Dunn IF; Herold-Mende C
Adv Exp Med Biol; 2023; 1416():199-211. PubMed ID: 37432629
[TBL] [Abstract][Full Text] [Related]
10. Modeling Meningiomas: Optimizing Treatment Approach.
Khan M; Hanna C; Findlay M; Lucke-Wold B; Karsy M; Jensen RL
Neurosurg Clin N Am; 2023 Jul; 34(3):479-492. PubMed ID: 37210136
[TBL] [Abstract][Full Text] [Related]
11. A novel NF2 splicing mutant causes neurofibromatosis type 2 via liquid-liquid phase separation with large tumor suppressor and Hippo pathway.
Jia Z; Yang S; Li M; Lei Z; Ding X; Fan M; Wang D; Xie D; Zhou H; Qiu Y; Zhuang Q; Li D; Yang W; Qi X; Cang X; Zhao JW; Wang W; Lin A; Yan Q
iScience; 2022 Nov; 25(11):105275. PubMed ID: 36300003
[TBL] [Abstract][Full Text] [Related]
12. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
Choudhury A; Magill ST; Eaton CD; Prager BC; Chen WC; Cady MA; Seo K; Lucas CG; Casey-Clyde TJ; Vasudevan HN; Liu SJ; Villanueva-Meyer JE; Lam TC; Pu JK; Li LF; Leung GK; Swaney DL; Zhang MY; Chan JW; Qiu Z; Martin MV; Susko MS; Braunstein SE; Bush NAO; Schulte JD; Butowski N; Sneed PK; Berger MS; Krogan NJ; Perry A; Phillips JJ; Solomon DA; Costello JF; McDermott MW; Rich JN; Raleigh DR
Nat Genet; 2022 May; 54(5):649-659. PubMed ID: 35534562
[TBL] [Abstract][Full Text] [Related]
13. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E
Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080
[TBL] [Abstract][Full Text] [Related]
14. Cell-cell adhesion regulates Merlin/NF2 interaction with the PAF complex.
Roehrig AE; Klupsch K; Oses-Prieto JA; Chaib S; Henderson S; Emmett W; Young LC; Surinova S; Blees A; Pfeiffer A; Tijani M; Brunk F; Hartig N; Muñoz-Alegre M; Hergovich A; Jennings BH; Burlingame AL; Rodriguez-Viciana P
PLoS One; 2021; 16(8):e0254697. PubMed ID: 34424918
[TBL] [Abstract][Full Text] [Related]
15. Mouse Models in Meningioma Research: A Systematic Review.
Boetto J; Peyre M; Kalamarides M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359639
[TBL] [Abstract][Full Text] [Related]
16. EANO guideline on the diagnosis and management of meningiomas.
Goldbrunner R; Stavrinou P; Jenkinson MD; Sahm F; Mawrin C; Weber DC; Preusser M; Minniti G; Lund-Johansen M; Lefranc F; Houdart E; Sallabanda K; Le Rhun E; Nieuwenhuizen D; Tabatabai G; Soffietti R; Weller M
Neuro Oncol; 2021 Nov; 23(11):1821-1834. PubMed ID: 34181733
[TBL] [Abstract][Full Text] [Related]
17. Characterization and comparison of genomic profiles between primary cancer cell lines and parent atypical meningioma tumors.
Kim E; Kim M; So K; Park YS; Woo CG; Hyun SH
Cancer Cell Int; 2020; 20():345. PubMed ID: 32742192
[TBL] [Abstract][Full Text] [Related]
18. Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.
Zhang H; Qi L; Du Y; Huang LF; Braun FK; Kogiso M; Zhao Y; Li C; Lindsay H; Zhao S; Injac SG; Baxter PA; Su JM; Stephan C; Keller C; Heck KA; Harmanci A; Harmanci AO; Yang J; Klisch TJ; Li XN; Patel AJ
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32517016
[TBL] [Abstract][Full Text] [Related]
19. KLF4
von Spreckelsen N; Waldt N; Poetschke R; Kesseler C; Dohmen H; Jiao HK; Nemeth A; Schob S; Scherlach C; Sandalcioglu IE; Deckert M; Angenstein F; Krischek B; Stavrinou P; Timmer M; Remke M; Kirches E; Goldbrunner R; Chiocca EA; Huettelmaier S; Acker T; Mawrin C
Acta Neuropathol Commun; 2020 Apr; 8(1):41. PubMed ID: 32245394
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2).
Shen YC; Arellano-Garcia C; Menjivar RE; Jewett EM; Dohle W; Karchugina S; Chernoff J; Potter BVL; Barald KF
BMC Pharmacol Toxicol; 2019 Nov; 20(1):67. PubMed ID: 31730023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
